E3 ligase

E3 ligase inhibitors and ligands act on the enzymes that transfer ubiquitin to substrate proteins. In the ubiquitin system an E1 activating enzyme, an E2 conjugating enzyme and an E3 ligase together mark proteins for proteasomal degradation. The E3 ligase sets substrate specificity, which makes these enzymes a common entry point for induced protein degradation. Thalidomide binds cereblon, a substrate receptor of a cullin 4 ubiquitin ligase, and avadomide belongs to the same chemical class. SKPin C1 acts on S-phase kinase-associated protein 2 (Skp2), while HLI 373 and TAME address the human double minute 2 (HDM2) ligase and the anaphase-promoting complex.

1 Item

  • BIO-2007817
    Cat. No.
    A24241

    BIO-2007817

    BIO-2007817 is a positive allosteric modulator (PAM) of Parkin, an E3 ubiquitin ligase. It enhances the activity of wild-type Parkin by stimulating its autoubiquitination and promotes the monoubiquitination of Miro1, with an EC50 of 0.17 μM. BIO-2007817 is a valuable tool for studying Parkin-mediated mitophagy and neurodegenerative diseases such as Parkinson's disease.

    5 mg
    $144.00
    10 mg
    $248.00
    All 4 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...